Feature partnership third party author requirements
When booking a Feature Partnership with European Pharmaceutical Review you are required to source a third-party article from a client of yours. The article should focus on a project that you have both worked on together, thereby highlighting your partnership.
The third-party article should from an organisation of your choice that matches the below criteria.
Type of organisation | Examples |
Pharma/Biopharma Company | AbbVie, AstraZeneca, Bayer BioNTech, Eli Lilly and Company, Gilead Sciences, GSK, Merck & Co. (MSD), Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceuticals etc. Achilles Therapeutics, Astellas Gene Therapies, bluebird bio, MeiraGTx, Regeneron, Vertex Pharmaceuticals etc. |
Contract Development/Manufacturing Organisations (CDMOs or CMOs) | Almac, Cambrex, Catalent, Lonza, Patheon, PCI Pharma, Recipharm AB, Samsung Biologics, WuXi Biologics etc. |
Academic organisations | Copenhagen University, Duke University, Harvard University, Imperial College London, University College London, University of Cambridge, University of Oxford, University of Manchester, University of Pennsylvania etc. |
R&D or industry organisations | AMR Industry Alliance, BioPhorum, Centre for Process Innovation (CPI), European Federation of Pharmaceutical Industries and Associations, National Institute for Bioprocessing Research and Training (NIBRT), Pistoia Alliance etc. |
